Home › Bipolar Disorder › Ohio
Bipolar Disorder clinical trials in Ohio
6 studies for Bipolar Disorder are looking for participants at sites in Ohio.
Cities in Ohio
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- University of Cincinnati Medical Center, Cincinnati
- Charak Center for Health and Wellness, Garfield Heights
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 25, 2026 · NCT06372964Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- University of Cincinnati Medical Center, Cincinnati
- Charak Center for Health and Wellness, Garfield Heights
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Independence
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- University Of Cincinnati Medical Center /ID# 274160, Cincinnati
- The Ohio State University /ID# 272954, Columbus
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 14, 2026 · NCT06696755Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
- University of Cincinnati College of Medicine, Cincinnati
RecruitingMentions payment for participants
Ages 12 to 21 · All sexes · Updated Apr 22, 2026 · NCT06920940Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
- University Hospitals Cleveland Medical Center - Mood Disorders Program, Cleveland
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT03829787From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.